Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
87,486,065
-
Share change
-
-1,581,501
-
Total reported value
-
$501,300,833
-
Put/Call ratio
-
44%
-
Price per share
-
$5.73
-
Number of holders
-
98
-
Value change
-
-$8,812,924
-
Number of buys
-
34
-
Number of sells
-
44
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2018
As of 30 Jun 2018,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,486,065 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, BlackRock Inc., GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, and JENNISON ASSOCIATES LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.